Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (93)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Blockmans, D.
Right arrow Articles by Mortelmans, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blockmans, D.
Right arrow Articles by Mortelmans, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology, Vol 38, 444-447, Copyright © 1999 by British Society for Rheumatology

ORIGINAL PAPERS

New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography

D Blockmans, A Maes, S Stroobants, J Nuyts, G Bormans, D Knockaert, H Bobbaers and L Mortelmans
Department of General Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium.

OBJECTIVE: To study the possible contribution of fluorodeoxyglucose (FDG)-positron emission tomography (PET) in the diagnosis of giant cell arteritis and polymyalgia rheumatica. METHODS: A consecutive case series consisting of five patients with polymyalgia rheumatica, six patients with temporal arteritis and 23 age-matched patients with other inflammatory conditions were evaluated with FDG-PET. Studies were performed before therapy with steroids was started. RESULTS: A total of 4/6 patients with giant cell arteritis and 4/5 patients with polymyalgia had increased FDG uptake in their thoracic vessels, compared to 1/23 controls (P < 0.001). Increased vascular FDG uptake in the upper legs was seen in 8/11 patients with giant cell arteritis or polymyalgia compared to 8/23 control patients (P < 0.05), and in the lower legs in 6/11 patients compared to 6/23 controls (P = not significant). CONCLUSIONS: FDG-PET scan is the first non-invasive technique which may indicate large-vessel vasculitis and which can show its extension throughout the body. It strongly suggests that polymyalgia rheumatica is a form of vasculitis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
D. Blockmans, W. Coudyzer, S. Vanderschueren, S. Stroobants, D. Loeckx, S. Heye, L. De Ceuninck, G. Marchal, and H. Bobbaers
Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis
Rheumatology, August 1, 2008; 47(8): 1179 - 1184.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
N. Pipitone, A. Versari, and C. Salvarani
Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update
Rheumatology, April 1, 2008; 47(4): 403 - 408.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
D. Blockmans, L. De Ceuninck, S. Vanderschueren, D. Knockaert, L. Mortelmans, and H. Bobbaers
Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients
Rheumatology, April 1, 2007; 46(4): 672 - 677.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
F Moosig, N Czech, C Mehl, E Henze, R A Zeuner, M Kneba, and J O Schroder
Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study
Ann Rheum Dis, July 1, 2004; 63(7): 870 - 873.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
T. Belhocine
The right place of 18FDG PET for the diagnosis of giant cell arteritis--a response to the article of Brodmann et al.
Rheumatology, May 1, 2004; 43(5): 675 - 676.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
M. Brodmann, R. W. Lipp, A. Passath, G. Seinost, E. Pabst, and E. Pilger
The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries
Rheumatology, February 1, 2004; 43(2): 241 - 242.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
V. M. Martinez-Taboada, M. J. Bartolome, M. D. Fernandez-Gonzalez, R. Blanco, V. Rodriguez-Valverde, and M. Lopez-Hoyos
Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy
Rheumatology, September 1, 2003; 42(9): 1055 - 1061.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C. M. Weyand and J. J. Goronzy
Medium- and Large-Vessel Vasculitis
N. Engl. J. Med., July 10, 2003; 349(2): 160 - 169.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. Horger, M. Muller-Schimpfle, M. Wehrmann, B. Mehnert, F. Maurer, S. M. Eschmann, and C. C. Claussen
Giant Bilateral Inflammatory Pseudotumor Arising Along the Arterial Sheath of the Lower Extremities
Am. J. Roentgenol., September 1, 2002; 179(3): 637 - 639.
[Full Text] [PDF]

Home page
 NEJMHome page
C. Salvarani, F. Cantini, L. Boiardi, and G. G. Hunder
Polymyalgia Rheumatica and Giant-Cell Arteritis
N. Engl. J. Med., July 25, 2002; 347(4): 261 - 271.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
W. A. Schmidt and E. Gromnica-Ihle
Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries
Rheumatology, January 1, 2002; 41(1): 46 - 52.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
H Marzo-Ortega, D McGonagle, P O'Connor, C Pease, and P Emery
Subclinical vasculitis in polymyalgia rheumatica
Ann Rheum Dis, November 1, 2001; 60(11): 1058 - 1059.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
A. Turlakow, H. W. D. Yeung, J. Pui, H. Macapinlac, E. Liebovitz, V. Rusch, A. Goy, and S. M. Larson
Fludeoxyglucose Positron Emission Tomography in the Diagnosis of Giant Cell Arteritis
Arch Intern Med, April 9, 2001; 161(7): 1003 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
A. M. Peters
Nuclear medicine in vasculitis
Rheumatology, May 1, 2000; 39(5): 463 - 470.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.